Despite the availability of several new systemic agents for psoriasis treatment, choosing the
right therapy in certain patient populations can be challenging. There are few up-to-date …

Antibodies are highly potent therapeutic scaffolds with more than a hundred different
products approved on the market. Successful development of antibody-based drugs …

BACKGROUND & AIMS: Some women with inflammatory bowel disease require therapy
with tumor necrosis factor (TNF) antagonists during pregnancy. It is not clear whether these …

Fistulating Crohn's disease (CD) comprises fistulae arising in the perianal area, together
with those communicating between the intestine and other organs or the abdominal wall …

1.0 Background Psoriasis is a common, chronic inflammatory skin disease which typically
follows a relapsing and remitting course, and is associated with joint disease in …

There are profound differences in maternofetal transfer of immunoglobulins between
species with extensive gestational transfer of maternal immunoglobulins in primates …

The introduction of biologic therapy with therapeutic monoclonal antibodies to the treatment
strategies of inflammatory bowel disease (IBD) has significantly changed the way clinicians …

Women with inflammatory bowel disease (IBD) have similar rates of fertility to the general
population, but have an increased rate of adverse pregnancy outcomes compared with the …

Over the past 2 decades, considerable progress has been made to further elucidate the
complex pathogenesis of psoriasis, facilitating the development of a new armamentarium of …

Inflammatory bowel diseases (IBD) typically affect patients in their reproductive years. It has
been shown that reproductive issues are of key concern to IBD patients, 1 especially …